<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-2295</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">36588894</article-id>
      <article-id pub-id-type="pmc">9796574</article-id>
      <article-id pub-id-type="doi">10.3389/fneur.2022.923942</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Neurology</subject>
          <subj-group>
            <subject>Mini Review</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neuroimaging biomarkers of cognitive recovery after ischemic stroke</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tahmi</surname>
            <given-names>Mouna</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="fn002" ref-type="author-notes">
<sup>†</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/886878/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kane</surname>
            <given-names>Veronica A.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="fn002" ref-type="author-notes">
<sup>†</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/2102236/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pavol</surname>
            <given-names>Marykay A.</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/2093665/overview"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Naqvi</surname>
            <given-names>Imama A.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref>
          <xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/459329/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Neurology, State University of New York Downstate Health Sciences University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Department of Neurology and Rehabilitation and Regenerative Medicine, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
      <aff id="aff4"><sup>4</sup><institution>Division of Stroke and Cerebrovascular Diseases, Department of Neurology, Columbia University</institution>, <addr-line>New York, NY</addr-line>, <country>United States</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Keith Pennypacker, University of Kentucky, United States</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Viktoria Fruhwirth, Medical University of Graz, Austria</p>
        </fn>
        <corresp id="c001">*Correspondence: Imama A. Naqvi <email>ian2108@cumc.columbia.edu</email></corresp>
        <fn fn-type="other" id="fn001">
          <p>This article was submitted to Stroke, a section of the journal Frontiers in Neurology</p>
        </fn>
        <fn fn-type="equal" id="fn002">
          <p>†These authors share first authorship</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>14</day>
        <month>12</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>13</volume>
      <elocation-id>923942</elocation-id>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>4</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2022 Tahmi, Kane, Pavol and Naqvi.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Tahmi, Kane, Pavol and Naqvi</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Post-stroke cognitive impairment affects more than one-third of patients after an ischemic stroke (IS). Identifying markers of potential cognitive recovery after ischemic stroke can guide patients' selection for treatments, enrollment in clinical trials, and cognitive rehabilitation methods to restore cognitive abilities in post-stroke patients. Despite the burden of post-stroke cognitive impairment, biomarkers of cognitive recovery are an understudied area of research. This narrative review summarizes and critically reviews the current literature on the use and utility of neuroimaging as a predictive biomarker of cognitive recovery after IS. Most studies included in this review utilized structural Magnetic Resonance Imaging (MRI) to predict cognitive recovery after IS; these studies highlighted baseline markers of cerebral small vessel disease and cortical atrophy as predictors of cognitive recovery. Functional Magnetic Resonance Imaging (fMRI) using resting-state functional connectivity and Diffusion Imaging are potential biomarkers of cognitive recovery after IS, although more precise predictive tools are needed. Comparison of these studies is limited by heterogeneity in cognitive assessments. For all modalities, current findings need replication in larger samples. Although no neuroimaging tool is ready for use as a biomarker at this stage, these studies suggest a clinically meaningful role for neuroimaging in predicting post-stroke cognitive recovery.</p>
      </abstract>
      <kwd-group>
        <kwd>ischemic stroke</kwd>
        <kwd>reperfusion</kwd>
        <kwd>recovery</kwd>
        <kwd>reorganization</kwd>
        <kwd>neuroplasticity</kwd>
        <kwd>neuroimaging</kwd>
        <kwd>cognition</kwd>
      </kwd-group>
      <counts>
        <fig-count count="1"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="59"/>
        <page-count count="12"/>
        <word-count count="7511"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>The American Heart Association (AHA) and the American Stroke Association (ASA) define ischemic stroke (IS) as an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction (<xref rid="B1" ref-type="bibr">1</xref>). IS represents 80% of all stroke types (<xref rid="B2" ref-type="bibr">2</xref>) and is a major cause of disability (<xref rid="B3" ref-type="bibr">3</xref>). With increasing survival after stroke and population aging, the prevalence of stroke is projected to increase by 3.4 million in 2030 (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Many patients who survive a stroke live with a significant long-term disability that affects multiple functions, including motor, sensory, language, and cognitive abilities. An increasing number of studies have attempted to determine potential factors that can influence recovery after stroke (<xref rid="B6" ref-type="bibr">6</xref>). In a pivotal report from the Stroke Rehabilitation Roundtable, the importance of using a biomarker approach to identify the potential for recovery after stroke was outlined (<xref rid="B6" ref-type="bibr">6</xref>). The consensus introduced the term Stroke Recovery Biomarker (SRB), defined as “indicators of disease state that can be used clinically as a measure reflecting underlying processes that may be difficult to measure directly in humans and could be used to predict recovery or treatment response” (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). The report referred to recovery for several stroke-type deficits, including motor, sensory, language, and cognition. The SRB approach aims to guide patients' treatment selection, enrollment in clinical trials, and rehabilitation interventions (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>).</p>
      <p>IS recovery studies have focused mostly on motor recovery (<xref rid="B8" ref-type="bibr">8</xref>–<xref rid="B20" ref-type="bibr">20</xref>). Cognition is another important domain frequently affected by IS, resulting in post-stroke cognitive impairment (PSCI). A recent systematic review and meta-analysis identified a pooled prevalence of PSCI of 39%, measured within the first year post-stroke (<xref rid="B21" ref-type="bibr">21</xref>). Others report a PSCI prevalence ranging from 20 to 80% depending on factors such as race and methodology (<xref rid="B22" ref-type="bibr">22</xref>). Cognitive recovery remains an understudied aspect of stroke, and no biomarkers are currently ready for use in clinical trials (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Some studies reported spontaneous restoration of cognitive function after the subacute phase of IS (<xref rid="B24" ref-type="bibr">24</xref>–<xref rid="B26" ref-type="bibr">26</xref>). However, many patients have cognitive impairment beyond the subacute phase of IS. A recent, large, population-based study of first-ever stroke patients from the South London Stroke Register between 1995 and 2018 (<italic>n</italic> = 6,504, mean age = 73 years) found that one-third of patients cognitively improved during the first 3 months post-stroke, one-third deteriorated, and the rest remained cognitively unchanged (<xref rid="B27" ref-type="bibr">27</xref>). The study further reported that PSCI was associated with a 5-year increase in the risk of mortality (RR = 30%), dependency (RR = 90%), depression (RR = 60%) and institutionalization (RR = 50%) (<xref rid="B27" ref-type="bibr">27</xref>).</p>
      <p>Imaging is a potential biomarker for cognitive recovery after IS (<xref rid="B6" ref-type="bibr">6</xref>). A systematic review evaluating all biological and imaging markers found that global atrophy and medial temporal lobe atrophy were the most consistent predictors of cognitive impairment after stroke; however, this review did not link cognitive recovery over time with neuroimaging (<xref rid="B28" ref-type="bibr">28</xref>). Given the accessibility and the wide use of neuroimaging as part of stroke workup, neuroimaging is a promising tool to study the potential for cognitive recovery after stroke. Neuroimaging techniques are currently being used to understand higher cortical function and recovery among comatose patients with the eventual goal to identify potential early and tailored rehabilitative interventions and underlying patient-specific characteristics that are most responsive to these interventions (<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>). Cognitive aging is another area where neuroimaging is increasingly used to comprehend brain cognitive processes (<xref rid="B31" ref-type="bibr">31</xref>). Thus, our goal for this review was to summarize literature within the last 10 years describing neuroimaging as a predictive marker of cognitive recovery in IS. We focus on IS, the most common type of stroke associated with PSCI. We highlight important findings and limitations in the studies and discuss some of the challenges for future studies to consider.</p>
    </sec>
    <sec id="s2">
      <title>Search methodology and literature selection</title>
      <p>PubMed was used as the primary database for studies published in the last 10 years through September 6th, 2022. We used the Medical Subject Headings (MeSH) term “stroke” with the MeSH subheadings “complications” or “psychology” or the term “ischemic stroke” paired with both of the following terms in the abstract/title of each article or as MeSH terms:</p>
      <list list-type="bullet">
        <list-item>
          <p>A cognition term (“cognition,” “cognitive,” “cognitive decline,” “cognition disorder,” or “dementia,” “neuropsychological,” or “neuropsychological tests”).</p>
        </list-item>
        <list-item>
          <p>A neuroimaging term (“neuroimaging,” “magnetic resonance imaging/MRI,” “functional magnetic resonance imaging/fMRI,” “diffusion tensor imaging/DTI,” “default mode network,” or “connectivity”).</p>
        </list-item>
      </list>
      <p>Additional studies obtained through review of relevant article citations were included.</p>
      <p>Studies examining other types of strokes—hemorrhagic stroke (HS), traumatic stroke, subarachnoid hemorrhage (SH), and transient ischemic attacks (TIA)—were excluded. HS were excluded due to their different recovery trajectories compared to IS (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Likewise, TIA were also excluded due to a lack of clear and persistent ischemic injury, which may result in a different recovery course (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>). Since cognitive recovery implies a change in cognitive performance over time, studies that reported only one cognitive assessment were excluded. Included studies associated a change in a cognitive assessment measure between at least two time points with baseline neuroimaging.</p>
      <p>Finally, we required baseline imaging and cognitive assessments to be completed within 6 weeks of stroke. This is to ensure clinical relevance, as most imaging used to predict recovery would be completed during a hospital admission. A baseline cognitive assessment more than 6 weeks after an initial ischemic stroke may represent a different stage of stroke recovery and therefore not comparable to the other articles in this review.</p>
      <p>Studies of potential relevance were selected, and 35 were excluded after careful full-text review based on the criteria detailed above (<xref rid="F1" ref-type="fig">Figure 1</xref>, <xref rid="SM1" ref-type="supplementary-material">Supplementary Table 1</xref>). A total of 13 studies were included.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Flow diagram of study selection process.</p>
        </caption>
        <graphic xlink:href="fneur-13-923942-g0001" position="float"/>
      </fig>
    </sec>
    <sec id="s3">
      <title>Neuroimaging modalities used as biomarkers for cognitive recovery after ischemic stroke</title>
      <sec>
        <title>MRI: T1-weighted MRI, T2-weighted, and fluid-attenuated inversion recovery (FLAIR)</title>
        <p>MRI as a means of characterizing or predicting cognitive impairment through structural biomarkers is well-documented (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B36" ref-type="bibr">36</xref>). These biomarkers include cerebral small vessel disease (SVD) such as white matter hyperintensities (WMH) and microinfarcts, cortical volume, and size and location of IS lesions (<xref rid="B36" ref-type="bibr">36</xref>). Researchers have attempted to use these same biomarkers to predict cognitive recovery following IS (<xref rid="B37" ref-type="bibr">37</xref>–<xref rid="B39" ref-type="bibr">39</xref>). Studies utilizing structural MRI that fit the criteria for this review are summarized in <xref rid="T1" ref-type="table">Table 1</xref>.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Summary of key studies within the last 10 years on neuroimaging biomarkers of cognitive recovery after ischemic stroke.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>References</bold>
</th>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Study population, <italic>N</italic>, type of stroke, age</bold>
</th>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Duration of study</bold>
</th>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Type of imaging and imaging outcomes examined</bold>
</th>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Cognitive measures</bold>
</th>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Findings</bold>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
<bold>fMRI</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Vicentini et al. (<xref rid="B40" ref-type="bibr">40</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">First subacute IS patients with no previous known neurologic disorder. Time 1 (<italic>n</italic> = 37, mean age = 62.92 ± 9.49 years, stroke onset = 24.32 ± 7.44 days, NIHSS: 2.66 ± 3.45). Time 2 after 6 months (<italic>n</italic> = 20, stroke onset: 182.05 ± 8.17 days). Cognitively healthy controls (<italic>n</italic> = 20)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">6 months: 2-time points.<break/> fMRI and cognitive assessments were done at time 1 (subacute phase, within the first month) and 2 (chronic phase, after 6 months).</td>
                <td valign="top" align="left" rowspan="1" colspan="1">rsFC<break/> Three networks were examined: DMN, SN, and CEN network.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA</td>
                <td valign="top" align="left" rowspan="1" colspan="1">At time 1<break/> Patients had weaker interhemispheric connectivity in the DMN than controls (<italic>p</italic> = 0.028, FDR-corrected).<break/> Better cognitive performance was associated with a stronger interhemispheric (<italic>r</italic> = 0.409, FDR <italic>p</italic> = 0.058) and ipsilesional DMN connectivity (<italic>r</italic> = 449, FDR <italic>p</italic> = 0.068) and weaker contralesional SN connectivity (<italic>r</italic> = −0.426, FDR <italic>p</italic> = 0.049)<break/> At time 2<break/> No change in functional connectivity in patients compared to time 1.<break/> Better cognitive recovery at time 2 was associated with stronger DMN connectivity (<italic>r</italic> = 0.511, FDR <italic>p</italic> = 0.090) and weaker SN interhemispheric subacute connectivity (<italic>r</italic> = −0.638, FDR <italic>p</italic> = 0.076)</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
<bold>MRI: T1-weighted MRI, T2-weighted MRI, FLAIR</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Fruhwirth et al. (<xref rid="B41" ref-type="bibr">41</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Recent small subcortical infarct (RSSI) patients (≤ 25 mm), no preexisting cognitive impairment (<italic>N</italic> = 82, mean age = 61 ± 10 years, 23% female)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">15 months:<break/> Baseline cognitive assessment at time 1 (mean 6 days post-stroke) and time 2 (15 months).<break/> MRI at Time 1.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">WMH lesion volume.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA, Symbol Digital Modalities Test, Comprehensive Trail Making Test</td>
                <td valign="top" align="left" rowspan="1" colspan="1">All patients improved on MoCA, SDMT (processing speed) after 15 months, regardless of WMH severity (<italic>p</italic> = 0.011 for MoCA, <italic>p</italic> = 0.010 for SDMT (processing speed); after age adjustment, no difference between WMH severity and MoCA (<italic>p</italic> = 0.109) or SDMT (processing speed) (<italic>p</italic> = 0.414).<break/> No differences between CTMT-2 (attention) scores and WMH.</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1">CTMT-5 (set-shifting): no improvement for patients with mild (<italic>p</italic> = 0.086) or moderate-severe WMH (<italic>p</italic> = 0.801) at 15 months, compared to improvement in patients without WMH (<italic>p</italic> = 0.001). Same results even when corrected for age.<break/> WMH volume at baseline was only significant factor that predicted attention at 15 month follow up (<italic>p</italic> = 0.002) beyond demographics.</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Scharf et al. (<xref rid="B42" ref-type="bibr">42</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Acute first-ever ischemic thalamic stroke, &gt;18 yo<break/> Exclusion: previous psychiatric/neuro disorders (<italic>N</italic> = 37 case, 37 controls)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">2 years:<break/> Neuropsychological assessment at time 1 (1 month), time 2 (6 month), time 3 (12 month) and time 4 (24 month)<break/> MRI at time 1, time 2, and time 4.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MRI—T1, T2, FLAIR, DWI</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Digit span, rivermead behavioral memory test, Regensburg semantic and phonemic word fluency, TMA A/B, Stroop</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Paramedian thalamic stroke patients demonstrated moderate language and executive deficits, with the best recovery of the three thalamic stroke topographies.<break/> Anterior thalamic stroke patients demonstrated the most severe deficits in verbal memory, language, and executive functions, which poorly recovered during follow-up.<break/> Inferolateral stroke patients also suffered from verbal memory, language, and executive deficits; the verbal memory and executive deficits recovered during follow-up, while the language deficits persisted.</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B38" ref-type="bibr">38</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (<italic>n</italic> = 199, mean age = 65 ± 13, NIHSS median = 3 (4)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">1 year: cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year).<break/> MRI was done at time 1 only (baseline between 24 and 72 h).</td>
                <td valign="top" align="left" rowspan="1" colspan="1">WMH, deep and lobar microbleeds, enlarged perivascular spaces in basal ganglia and centrum semiovale, previous small deep infarcts, and cSS.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> ZCT processing speed and attention<break/> IST of verbal fluency for executive function.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">- Cognitive performance improved more significantly in the first 3 months. - Severe WMH was identified in 34% of the patients, and cSS in 3.5%.<break/> Patients with severe WMH and focal cSS had overall worse cognitive performances.</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1"/>
                <td valign="top" align="left" rowspan="1" colspan="1">- Patient with severe WMH had less improvement over time in IST of verbal fluency (β = −0.16, <italic>p</italic> = 0.02) and the number of errors to ZCT (β = 0.19, <italic>p</italic> = 0.02). Those with focal cSS had less improvement over time for ZCT completion time (β = 0.14, <italic>p</italic> = 0.01) and number of errors (β = 0.17, <italic>p</italic> = 0.008).</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B39" ref-type="bibr">39</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Acute Ischemic supratentorial stroke patients with no previous neuropsychiatric disorder or dementia (<italic>n</italic> = 199, mean age = 67 ± 14, NIHSS ≥1)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">One year: 3-time points cognitive assessment was done at time 1 (baseline), time 2 (after 3 months), and time 3 (after 1 year).<break/> MRI was done at time 1 only (baseline between 24 and 72 h)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">CMI.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> The Zazzo's cancellation task (ZCT) for processing speed and attention<break/> Issac set a test for verbal fluency (IST)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">The number of CMI was associated with increased time at the ZCT over 1 year regardless of the other MRI markers, stroke severity, and demographic factors (B = 3.84, <italic>P</italic> = 0.01).</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Sagnier et al. (<xref rid="B43" ref-type="bibr">43</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Acute supratentorial ischemic stroke without prestroke disability related to neurological disorder, mRS &gt; 1 at baseline (<italic>N</italic> = 248, mean age 65 ± SD 14 years old, 66% men)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">12 months:<break/> Baseline MRI<break/> Cognitive assessment at time 1 (within 24–72 h), time 2 (after 3 months), and time 3 (after 12 months)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">WMH + stroke volume, gray matter (GM), white matter, and CSF volume.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Cognitive assessment: MoCA, Isaacs Set Test (IST), Zazzo's cancellation test<break/> Cognitive improvement, stability, or decline calculated using all 3 time points</td>
                <td valign="top" align="left" rowspan="1" colspan="1">- Radiographic model only: total GM volume was the only variable predictive of changes in all cognitive scores over the year of follow-up (<italic>P</italic> &lt; 0.001 for MoCA, <italic>P</italic> = 0.03 for IST, <italic>P</italic> = 0.002 for time to perform Zazzo's cancellation task and <italic>P</italic> &lt; 0.001 for the number of errors)<break/> - In clinical/radiographic model: total GM volume independently associated with cognition [MoCA (<italic>P</italic> = 0.04) and Zazzo's cancellation task (<italic>P</italic> = 0.04)] - GM volume of left fronto-temporo-insular regions, right temporo-insular cortex, and basal ganglia was significantly associated with cognitive improvement.</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Sung et al. (<xref rid="B44" ref-type="bibr">44</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">First ever ischemic stroke without specific etiologies predisposing to recurrence, cognitive impairment at baseline, neurodegenerative disease (<italic>n</italic> = 112, median age 64.5 (IQR 57.0–73.5) years, NIHSS at baseline 3.77 (IQR: 1.75–5).</td>
                <td valign="top" align="left" rowspan="1" colspan="1">1 year:<break/> MRI and cognitive assessment at time 1 (within 7 days), cognitive assessment again at time 2 (3 months) and time 3 (1 year)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Stroke location, SVD burden and hippocampal atrophy (HA)<break/> Modified cerebral small vessel disease (mCSVD) score calculated using lacunar infarction, microbleeds, moderate to severe perivascular space at the ganglionic level or a deep white matter Fazekas score ≥ 2.<break/> Medial temporal atrophy score used to determine hippocampal atrophy.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA<break/> Weschler Adult Intelligence Scale III, Wechsler Memory Scale III the Semantic Association of Verbal Fluency Test for semantic verbal fluency, Wisconsin Card Sorting Test</td>
                <td valign="top" align="left" rowspan="1" colspan="1">No significant difference in change in MOCA scores between higher CSVD burden or abnormal HA.<break/> In the multivariate model, higher mCSVD score (adjusted odds ratio (aOR) 2.74, 95%CI 1.09–6.86, <italic>p</italic> = 0.032) independently predicted low cognitive performance at 1 year [but not an abnormal MTA score (aOR 1.53, 95%CI 0.56–4.21, <italic>p</italic> = 0.405)]. A combination of a higher mCSVD score and an abnormal MTA score resulted in the highest probability of classification in the LP group (aOR 4.18, 95%CI 1.05–16.66, <italic>p</italic> = 0.043).</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Turunen et al. (<xref rid="B45" ref-type="bibr">45</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">First ever supratentorial ischemic stroke, no baseline neurological or psychiatric disorder (<italic>n</italic> = 132, mean age 54 years, 68.2% male)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">6 months:<break/> Baseline imaging<break/> Cognitive assessment at time 1 (~8 days post-stroke) and time 2 (6 month follow up)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Stroke location, categorized into two groups: infarction in cortical gray matter (including additional white matter) or infarction in subcortical gray and/or white matter.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Weschler memory scale, phonemic fluency task, TMA A/B, WMS-R, searching task<break/> On 6-month repeat, general intellect added</td>
                <td valign="top" align="left" rowspan="1" colspan="1">No differences in the recovery of cognitive profile amongst lesion location groups were found; after adjusting for baseline scores, the lesion location groups did not differ at follow-up.</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Zhang et al. (<xref rid="B46" ref-type="bibr">46</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Imaging confirmed first time acute ischemic stroke, no history of cognitive or psychiatric disorder (<italic>n</italic> = 865, mean age 59.67 ± 10.92 years and 74.22% male)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">12 months:<break/> Baseline imaging<break/> Baseline MOCA at time 1 (2 weeks/discharge) and time 2 (12 month follow-up)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Infarct location, small vessel disease features, WMHs, lacunes, microbleeds, enlarged perivascular spaces, cortical atrophy</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MOCA<break/> Cognitive decline defined as reduction of 2+ points between time 1 and time 2, improvement defined as increase of 2+ between time points, cognitive stability defined as change of &lt; 2 points.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">In cognitive decline group, statistically significantly higher incidence of thalamic (11.43 vs. 5.66%, <italic>p</italic> = 0.023) and right sided lesions (6.67 vs. 1.97%, <italic>p</italic> = 0.004).<break/> Thalamic infarction increased risk of cognitive decline (OR 2.152, 95% CI 1.095–4.227).<break/> Thalamic infarction quadrupled the risk of cognitive decline (OR 4.873, 95% CI 1.634–14.534) in fully adjusted model.</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
<bold>MRI: DTI, DWI</bold>
</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Aben et al. (<xref rid="B47" ref-type="bibr">47</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Ischemic stroke patients with no prior cognitive disorder [<italic>n</italic> = 75, mean age = 70 ±8.5, NIHSS =2 (2–4)]</td>
                <td valign="top" align="left" rowspan="1" colspan="1">1 year: 2- time points<break/> Cognitive assessments were done at time 1 (baseline 5 weeks ±1 week) and time 2 (after 1 year). MRI was done at time 1 only.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Lesion impact score, calculated by multiplying the percentage of node volume affected by the infarct with the node's corresponding hub-score.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">4 cognitive domains: attention and processing speed, working memory and learning, and frontal executive function</td>
                <td valign="top" align="left" rowspan="1" colspan="1">- A higher lesion impact score, indicating an increasing infarct size in nodes with a higher hub-score, was related to lower global brain network efficiency [β = −0.528 (−0.776 to −0.277); <italic>P</italic> &lt; 0.001].<break/> - A lower lesion impact score was an independent predictor of cognitive recovery 1 year after stroke [OR = 0.434 (0.193–0.978); <italic>P</italic> = 0.044].</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Aben et al. (<xref rid="B48" ref-type="bibr">48</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Ischemic stroke patients (<italic>n</italic> = 217, aged ≥50 years, and MoCA &lt; 26 during hospitalization)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">1 year: 2- time points<break/> Cognitive assessments were done at time 1 (baseline 5 weeks) and time 2 (after 1 year). MRI was done at time 1 only.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">4 DWI-based measures of brain connectivity: global network efficiency and mean connectivity strength, both weighted for MD and FA.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">MoCA</td>
                <td valign="top" align="left" rowspan="1" colspan="1">- Of 135 patients with PSCI at time 1, 41 (30%) showed cognitive recovery.<break/> three out of four DTI measures of brain connectivity: global efficiency FA weighted, mean connectivity strength FA weighted, and mean connectivity strength MD weighted predict cognitive recovery 1 year after IS. These measures, however, did not add a better predictive value over the multivariable model.</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Kuceyeski et al. (<xref rid="B49" ref-type="bibr">49</xref>)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">IS patients (<italic>n</italic> = 40, mean age = 68.1 ± 13.2 years, NIHSS: 6.8 ± 5.6)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">6 months<break/> Cognitive assessment after discharge and at 6 months.<break/> Imaging was done at baseline (within 14 days)</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Connectome disruption at three levels: whole brain, individual gray matter regions and between pairs of gray matter regions.<break/> Lesion volume model for comparison.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">Computer adaptive version of the Activity Measure for Post-Acute Care.</td>
                <td valign="top" align="left" rowspan="1" colspan="1">- The regional disconnection model best predicted applied cognitive functioning (<italic>R</italic><sup>2</sup> = 0.56)<break/> - The pairwise disconnection model best predicted the daily activity measure (<italic>R</italic><sup>2</sup> = 0.72)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>fMRI, Functional Magnetic Resonance Imaging; FLAIR, Fluid-Attenuated Inversion Recovery; DTI, Diffusion Tensor Imaging; DWI, Diffusion-Weighted Imaging; IS, Ischemic Stroke; rsFC, resting-state functional connectivity; DMN, Default Mode Network; SN, Salience Network; CEN, Central Executive network; MoCA, Montreal Cognitive Assessment; MMSE, Mini-Mental State Examination; PSCI, Post-Stroke Cognitive Impairment; PCC, Posterior Cingulate Cortex; PCu, Precuneus; MPFC, Medial Prefrontal Cortex; FIM, Functional-Independence Measures; WMH, White Matter Hyperintensities; NFL, Neurofilament Lights; ZCT, Zazzo's Cancellation Task; IST, Issac Set a Test; cSS, Cortical Superficial Siderosis; CMI, Cortical Cerebral Microinfarct; MD, Mean Diffusivity; FA, Fractional Anisotropy; GPT, Grooved Pegboard Test.</p>
          </table-wrap-foot>
        </table-wrap>
        <sec>
          <title>Markers of cerebral small vessel disease</title>
          <p>An important study by Sagnier et al. reported that first-time IS patients with pre-existing severe WMH on MRI had less improvement in verbal fluency tests at 3 months to 1 year after IS (<xref rid="B38" ref-type="bibr">38</xref>). Similarly, the presence of Cortical Superficial Siderosis (cSS) after first-time IS, another radiologic biomarker of cerebral SVD, was an indicator of worse cognitive recovery in tests of processing speed and attention, independent of IS volume/location, gray matter volume, other SVD biomarkers, and clinical severity, cardiovascular risk factors, and demographic confounders (<xref rid="B38" ref-type="bibr">38</xref>).</p>
          <p>Similarly, Fruthwirth et al. found that deep WMH volume at baseline predicted recovery of set-shifting at 15 month follow up among patients with recent small subcortical infarcts: participants with no or mild deep WMH improved in set-shifting, while those with moderate to severe WMH showed no improvement (<xref rid="B41" ref-type="bibr">41</xref>). A similar pattern was seen for periventricular WMH (pWMH) at baseline and recovery of attention, although this interaction was no longer significant after controlling for age. For set-shifting, mild pWMH predicted improvement, whereas no pWMH and moderate-severe pWMH demonstrated no improvement. Of note, this study found that all patients, regardless of baseline WMH volume, improved in Montreal Cognitive Assessment (MoCA) scores, processing speed, and attention.</p>
          <p>Another study examining cerebral small vessel disease (mCSVD) score—determined by MRI evaluation—and medial temporal atrophy (MTA) score—a measure of hippocampal atrophy—found that neither of these imaging markers predicted change in MoCA scores between baseline and 1 year follow up (<xref rid="B44" ref-type="bibr">44</xref>). Despite these imaging markers not being associated with a change in cognitive scores, this study did find that mCSVD and MTA scores could be used to predict low vs. high cognitive performance at 1 year, with higher mCSVD and MTA scores associated with increased likelihood of low MoCA scores at follow up.</p>
        </sec>
        <sec>
          <title>Cortical volume</title>
          <p>Sagnier found that total gray matter (GM) volume was the only radiographic factor predictive of cognitive improvement at 12 month follow up among IS patients. Specifically, GM volume of left fronto-temporo-insular regions, right temporo-insular cortex, and basal ganglia were significantly associated with cognitive improvement (<xref rid="B43" ref-type="bibr">43</xref>).</p>
        </sec>
        <sec>
          <title>Infarct characteristic</title>
          <p>Several studies examined the impact of infarct location on cognitive recovery using structural MRI. Turunen examined differences in cognitive recovery for cortical vs. subcortical lesions among patients with first-ever supratentorial ischemic stroke (<xref rid="B45" ref-type="bibr">45</xref>). While this study found that subcortical infarctions were associated with decreased verbal memory and psychomotor speed in the acute phase and persistent verbal memory differences at 6-month follow-up, there was no difference in recovery of cognition between the two lesion location groups. In contrast, a recent study by Zhang et al. found a significantly higher incidence of thalamic and right-sided lesions in the group that cognitively declined at follow up, determined by a difference in MoCA scores between baseline and 12-month exam (<xref rid="B46" ref-type="bibr">46</xref>). In their fully adjusted models, infarct in the thalamus more than quadrupled the risk of cognitive decline among these patients. A recent study further characterized cognitive recovery among patients with ischemic thalamic stroke: in this case control study with a 2-year follow-up period, patients with anterior and inferolateral thalamic strokes were found to have poorer recovery of language, memory, and executive function than those with paramedian strokes (<xref rid="B42" ref-type="bibr">42</xref>).</p>
          <p>Together, these studies support the use of structural MRI sequences to predict changes in cognition after ischemic stroke. Baseline measures of cerebral SVD, including WMH, as well as baseline cortical volume may be important indicators of the potential for restoration of cognitive ability after stroke. In addition, these articles suggest that different infarct locations as seen on structural MRI may be used to predict differing cognitive recovery trajectories after stroke, although more studies are needed to fully elucidate this relationship.</p>
        </sec>
      </sec>
      <sec>
        <title>Functional magnetic resonance imaging (fMRI)</title>
        <p>Only one study reported post-IS cognitive recovery using resting-state fMRI (rs-fMRI) (<xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B40" ref-type="bibr">40</xref>). Rs-fMRI utilizes Blood Oxygen Level Dependent (BOLD) to study spontaneous brain neural activity at rest in a specific functional brain region (rsfMRI activity) (<xref rid="B50" ref-type="bibr">50</xref>). In their study examining cognitive recovery after IS, Vincentini et al. found weaker interhemispheric spontaneous temporal correlations between different brain functional regions [rs-functional connectivity (rsFC)] within the Default Mode Network (DMN). Alterations of rsFc among IS patients have also been previously reported (<xref rid="B51" ref-type="bibr">51</xref>–<xref rid="B53" ref-type="bibr">53</xref>). Stroke injury has been shown to disrupt communications between hemispheres and results in both intra-and interhemispheric changes in rsFC (<xref rid="B52" ref-type="bibr">52</xref>). Vicentini et al. reported no change in rsFC from the subacute to the chronic phase in IS patients (<xref rid="B40" ref-type="bibr">40</xref>). This study did find, however, that better cognitive recovery at 6 months was correlated with rsFC in two networks: DMN and Executive Network (<xref rid="B40" ref-type="bibr">40</xref>).</p>
        <p>This study argues in favor of the potential of rsFC to predict the course of cognitive changes post-IS and the involvement of DMN in the recovery process, although more studies are required to confirm these findings and further understand brain functional networks involved in the acute to chronic phases of cognitive recovery (<xref rid="B20" ref-type="bibr">20</xref>). Furthermore, there are still practical challenges to using rsFMRI in clinical settings, such as availability, time, and the need for interpretation expertise. The lack of technique standardization, including variability in rsfMRI data acquisition, preprocessing, and analytical methods, presents another challenge for clinical applicability (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B54" ref-type="bibr">54</xref>).</p>
      </sec>
      <sec>
        <title>Diffusion tensor imaging (DTI) and diffusion-weighted imaging (DWI)</title>
        <p>While fMRI examines the brain's functional integrity, DTI looks at the brain's white matter structural integrity. Fractional anisotropy (FA) is the most common parameter derived from DTI to assess brain structural connectivity. Other DTI measures are mean diffusivity (MD), radial diffusivity (RD), axial diffusivity (AD), independent of direction, and relative anisotropy.</p>
        <p>Important studies using DTI/DWI to study cognitive recovery after IS are summarized in <xref rid="T1" ref-type="table">Table 1</xref>. A notable study by Aben et al. (<xref rid="B47" ref-type="bibr">47</xref>) used diffusion-weighted data after IS to create a lesion impact score that reflected the impact of IS size on the brain's network hubs. The authors demonstrated that a lower lesion impact score was an independent predictor of cognitive recovery 1 year after IS while controlling for WMH and infarct volumes (<xref rid="B47" ref-type="bibr">47</xref>). The authors showed that this score could also be calculated using structural MRI sequences (T1, FLAIR), which are routinely ordered as part of a stroke workup and therefore easier to implement in a clinical setting to predict long-term recovery after IS (<xref rid="B47" ref-type="bibr">47</xref>). A subsequent study compared DTI measures with a multivariable model, including age, education, and infarct size, and found that three out of four DTI measures of brain connectivity (global efficiency FA weighted, mean connectivity strength FA weighted, and mean connectivity strength MD weighted) predicted cognitive recovery 1 year after IS. These measures, however, did not improve prediction over the multivariable model that included education level and infarct size as significant predictors of cognitive recovery (<xref rid="B48" ref-type="bibr">48</xref>).</p>
        <p>In a different study using DWI, Kuceyeski et al. (<xref rid="B49" ref-type="bibr">49</xref>) compared models of connectome disruption to determine which model best predicted recovery after IS. The authors found that the regional disconnection model, which reflects changes in structural connectivity of gray matter regions (WM tracts connecting brain regions) to the rest of the network, best predicted cognitive recovery. This regional disconnection model was found to be superior to models based on lesion volume and other disconnection models (whole brain and pairwise) (<xref rid="B49" ref-type="bibr">49</xref>).</p>
        <p>The evidence for DTI and DWI as a means of predicting cognitive recovery after stroke is promising. More research is needed to determine the additional utility of this modality over structural MRI and to improve predictive value.</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Study limitations and future directions</title>
      <p>To the best of our knowledge, this review is among the first to focus on neuroimaging biomarkers of cognitive recovery among IS patients. This review is limited by inherent challenges in using keywords to search literature, including a lack of consistent use of terminology to characterize study subject matter. We carefully reviewed the literature to ensure our search was as robust as possible but may have inadvertently missed relevant studies. One key aspect of our study that necessitated the exclusion of multiple otherwise relevant articles was that we focused specifically on the association of neuroimaging with cognitive recovery after stroke; each included study reported on the association between baseline neuroimaging and a change in a cognitive measure over time. Articles that merely reported a cognitive outcome (e.g., post-stroke cognitive impairment vs. no post-stroke cognitive impairment) were therefore excluded from this review of neuroimaging biomarkers for cognitive recovery after IS.</p>
      <p>In addition, there are several gaps in the current literature, as discussed below:</p>
      <list list-type="order">
        <list-item>
          <p>The best time to study cognitive recovery remains unclear and likely stems from uncertainty in the time frame of expected cognitive recovery post-stroke. In our review, we focused on baseline cognitive assessments done within 6 weeks of stroke to ensure clinical relevance and to adequately compare different articles. However, cognitive recovery studies among chronic stroke patients may help answer this question.</p>
        </list-item>
        <list-item>
          <p>The ability to detect cognitive recovery depends largely on the sensitivity of the cognitive test used. The studies included in this review used a variety of different tests—all outlined in <xref rid="T1" ref-type="table">Table 1</xref>—which may limit our ability to compare them and to generalize their results. Screening tests such as the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Exam (MMSE) are gross measures of cognition and may not capture subtle cognitive dysfunction nor subtypes of cognitive impairment (e.g., left neglect, aphasia). MoCA, for instance, is less sensitive to right-hemispheric lesion-based deficits (<xref rid="B55" ref-type="bibr">55</xref>). Adequate studies of cognitive recovery may require more detailed assessments tailored to the setting (e.g., brief baseline exams for inpatients, longer baseline exams for outpatients).</p>
        </list-item>
        <list-item>
          <p>To be included in this review, we required at least one repeat measure of cognition. However, it should be noted that having longitudinal imaging is also important to show concordance between neuroimaging and cognitive testing parameters across the recovery course.</p>
        </list-item>
        <list-item>
          <p>Some studies—which were excluded from this review—utilized cohorts of both ischemic (IS) and hemorrhagic strokes (HS) to study cognitive recovery. IS and IH have different pathophysiologies and different recovery processes (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Although the differences in recovery between the two-stroke types are not entirely known (<xref rid="B56" ref-type="bibr">56</xref>), future post-stroke cognitive recovery studies should analyze stroke types separately.</p>
        </list-item>
        <list-item>
          <p>Only some of the reviewed studies explicitly assessed pre-stroke cognitive status. Pre-stroke cognitive status may influence the recovery process and should be taken into consideration (<xref rid="B57" ref-type="bibr">57</xref>). Similarly, not all studies mentioned if only first-time IS patients were included (<xref rid="B49" ref-type="bibr">49</xref>). In the future, it would be helpful to standardize screening of pre-stroke cognitive status to better allow comparison between studies of cognitive recovery.</p>
        </list-item>
        <list-item>
          <p>Finally, many studies in this review combined neuroimaging with non-neuroimaging tools to improve the prediction of cognitive recovery after IS. For example, Sangier created models that incorporated demographic and clinical factors, including age, sex, education, cardiovascular risk factors, and modified Rankin score (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Such models are currently used to predict cognitive function after stroke, suggesting their utility in predicting cognitive recovery post-stroke; the SIGNAL2 score and the CHANGE score, both examining the risk of post-stroke cognitive impairment, incorporate age and education into their prediction tools, in addition to imaging variables (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>).</p>
        </list-item>
      </list>
    </sec>
    <sec sec-type="conclusions" id="s5">
      <title>Conclusion</title>
      <p>In summary, the current literature on cognitive recovery using neuroimaging as a predictive marker, although small, is promising. No imaging tool is ready for use as an established biomarker yet. Future studies should replicate current findings in larger samples using a consistent methodology.</p>
    </sec>
    <sec sec-type="author-contributions" id="s6">
      <title>Author contributions</title>
      <p>MT and VK conducted the literature search and drafted the manuscript in equal contribution. MP reviewed the manuscript for intellectual content. IN conceptualized the project and reviewed the manuscript for intellectual content.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="funding-information" id="s7">
      <title>Funding</title>
      <p>IN was currently supported by National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number KL2TR001874 and has received institutional support from Columbia University of Vagelos College of Physicians, Doris Duke Charitable Foundation COVID-19 Fund to Retain Clinical Scientists, and the American Heart Association.</p>
    </sec>
    <sec sec-type="COI-statement" id="conf1">
      <title>Conflict of interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <sec sec-type="disclaimer" id="s8">
      <title>Publisher's note</title>
      <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
    </sec>
    <sec sec-type="supplementary-material" id="s9">
      <title>Supplementary material</title>
      <p>The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2022.923942/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fneur.2022.923942/full#supplementary-material</ext-link></p>
      <supplementary-material id="SM1" position="float" content-type="local-data">
        <media xlink:href="Table_1.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacco</surname><given-names>RL</given-names></name><name><surname>Kasner</surname><given-names>SE</given-names></name><name><surname>Broderick</surname><given-names>JP</given-names></name><name><surname>Caplan</surname><given-names>LR</given-names></name><name><surname>Connors</surname><given-names>JJ</given-names></name><name><surname>Culebras</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association</article-title>. <source>Stroke.</source> (<year>2013</year>) <volume>44</volume>:<fpage>2064</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1161/STR.0b013e318296aeca</pub-id><pub-id pub-id-type="pmid">23652265</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehndiratta</surname><given-names>P</given-names></name><name><surname>Chapman Smith</surname><given-names>S</given-names></name><name><surname>Worrall</surname><given-names>BB</given-names></name></person-group>. <article-title>Etiologic stroke subtypes: updated definition and efficient workup strategies</article-title>. <source>Curr Treat Options Cardiovasc Med</source>. (<year>2015</year>) <volume>17</volume>:<fpage>357</fpage>. <pub-id pub-id-type="doi">10.1007/s11936-014-0357-7</pub-id><pub-id pub-id-type="pmid">25398425</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virani</surname><given-names>SS</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Aparicio</surname><given-names>HJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Bittencourt</surname><given-names>MS</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name><etal/></person-group>. <article-title>Stroke statistics, heart disease and stroke statistics-2021 update: a report from the American Heart Association</article-title>. <source>Circulation.</source> (<year>2021</year>) <volume>143</volume>:<fpage>e254</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000950</pub-id><pub-id pub-id-type="pmid">33501848</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovbiagele</surname><given-names>B</given-names></name><name><surname>Goldstein</surname><given-names>LB</given-names></name><name><surname>Higashida</surname><given-names>RT</given-names></name><name><surname>Howard</surname><given-names>VJ</given-names></name><name><surname>Johnston</surname><given-names>SC</given-names></name><name><surname>Khavjou</surname><given-names>OA</given-names></name><etal/></person-group>. <article-title>Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association</article-title>. <source>Stroke</source>. (<year>2013</year>) <volume>44</volume>:<fpage>2361</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1161/STR.0b013e31829734f2</pub-id><pub-id pub-id-type="pmid">23697546</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Bittencourt</surname><given-names>MS</given-names></name><name><surname>Callaway</surname><given-names>CW</given-names></name><name><surname>Carson</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>Heart disease and stroke statistics-2019 update: a report from the American Heart Association</article-title>. <source>Circulation.</source> (<year>2019</year>) <volume>139</volume>:<fpage>e56</fpage>–<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000659</pub-id><pub-id pub-id-type="pmid">30700139</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>LA</given-names></name><name><surname>Hayward</surname><given-names>KS</given-names></name><name><surname>Ward</surname><given-names>NS</given-names></name><name><surname>Stinear</surname><given-names>CM</given-names></name><name><surname>Rosso</surname><given-names>C</given-names></name><name><surname>Fisher</surname><given-names>RJ</given-names></name><etal/></person-group>. <article-title>Biomarkers of stroke recovery: consensus-based core recommendations from the stroke recovery and rehabilitation roundtable</article-title>. <source>Neurorehabil Neural Repair.</source> (<year>2017</year>) <volume>31</volume>:<fpage>864</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1177/1545968317732680</pub-id><pub-id pub-id-type="pmid">29233071</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernhardt</surname><given-names>J</given-names></name><name><surname>Borschmann</surname><given-names>K</given-names></name><name><surname>Boyd</surname><given-names>L</given-names></name><name><surname>Carmichael</surname><given-names>ST</given-names></name><name><surname>Corbett</surname><given-names>D</given-names></name><name><surname>Cramer</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Moving rehabilitation research forward: developing consensus statements for rehabilitation and recovery research</article-title>. <source>Neurorehabil Neural Repair.</source> (<year>2017</year>) <volume>31</volume>:<fpage>694</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/1545968317724290</pub-id><pub-id pub-id-type="pmid">28803534</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwigsen</surname><given-names>G</given-names></name><name><surname>Saur</surname><given-names>D</given-names></name></person-group>. <article-title>Neuroimaging of stroke recovery from aphasia - insights into plasticity of the human language network</article-title>. <source>Neuroimage.</source> (<year>2019</year>) <volume>190</volume>:<fpage>14</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.11.056</pub-id><pub-id pub-id-type="pmid">29175498</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinke</surname><given-names>MRT</given-names></name><name><surname>van Tilborg</surname><given-names>GAF</given-names></name><name><surname>Meerwaldt</surname><given-names>AE</given-names></name><name><surname>van Heijningen</surname><given-names>CL</given-names></name><name><surname>van der Toorn</surname><given-names>A</given-names></name><name><surname>Straathof</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Remote corticospinal tract degeneration after cortical stroke in rats may not preclude spontaneous sensorimotor recovery</article-title>. <source>Neurorehabil Neural Repair</source>. (<year>2021</year>) <volume>35</volume>:<fpage>1010</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1177/15459683211041318</pub-id><pub-id pub-id-type="pmid">34546138</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattia</surname><given-names>D</given-names></name><name><surname>Pichiorri</surname><given-names>F</given-names></name><name><surname>Colamarino</surname><given-names>E</given-names></name><name><surname>Masciullo</surname><given-names>M</given-names></name><name><surname>Morone</surname><given-names>G</given-names></name><name><surname>Toppi</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a study protocol for a randomized controlled trial to test early and long-term efficacy and to identify determinants of response</article-title>. <source>BMC Neurol.</source> (<year>2020</year>) <volume>20</volume>:<fpage>254</fpage>. <pub-id pub-id-type="doi">10.1186/s12883-020-01826-w</pub-id><pub-id pub-id-type="pmid">32593293</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Dang</surname><given-names>C</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Network change in the ipsilesional cerebellum is correlated with motor recovery following unilateral pontine infarction</article-title>. <source>Eur J Neurol</source>. (<year>2019</year>) <volume>26</volume>:<fpage>1266</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13974</pub-id><pub-id pub-id-type="pmid">31021033</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>R</given-names></name><name><surname>Tong</surname><given-names>RK</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A longitudinal study of hand motor recovery after sub-acute stroke: a study combined FMRI with diffusion tensor imaging</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e64154</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0064154</pub-id><pub-id pub-id-type="pmid">23724030</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Longitudinal cortical volume changes correlate with motor recovery in patients after acute local subcortical infarction</article-title>. <source>Stroke.</source> (<year>2013</year>) <volume>44</volume>:<fpage>2795</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.113.000971</pub-id><pub-id pub-id-type="pmid">23929747</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarahn</surname><given-names>E</given-names></name><name><surname>Alon</surname><given-names>L</given-names></name><name><surname>Ryan</surname><given-names>SL</given-names></name><name><surname>Lazar</surname><given-names>RM</given-names></name><name><surname>Vry</surname><given-names>MS</given-names></name><name><surname>Weiller</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Prediction of motor recovery using initial impairment and fMRI 48 h poststroke</article-title>. <source>Cereb Cortex.</source> (<year>2011</year>) <volume>21</volume>:<fpage>2712</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhr047</pub-id><pub-id pub-id-type="pmid">21527788</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorga</surname><given-names>M</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Caplan</surname><given-names>D</given-names></name><name><surname>Zinbarg</surname><given-names>R</given-names></name><name><surname>Kiran</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>CK</given-names></name><etal/></person-group>. <article-title>Predicting language recovery in post-stroke aphasia using behavior and functional MRI</article-title>. <source>Sci Rep.</source> (<year>2021</year>) <volume>11</volume>:<fpage>8419</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-88022-z</pub-id><pub-id pub-id-type="pmid">33875733</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebastian</surname><given-names>R</given-names></name><name><surname>Long</surname><given-names>C</given-names></name><name><surname>Purcell</surname><given-names>JJ</given-names></name><name><surname>Faria</surname><given-names>AV</given-names></name><name><surname>Lindquist</surname><given-names>M</given-names></name><name><surname>Jarso</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Imaging network level language recovery after left PCA stroke</article-title>. <source>Restor Neurol Neurosci.</source> (<year>2016</year>) <volume>34</volume>:<fpage>473</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.3233/RNN-150621</pub-id><pub-id pub-id-type="pmid">27176918</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartwigsen</surname><given-names>G</given-names></name></person-group>. <article-title>Adaptive plasticity in the healthy language network: implications for language recovery after stroke</article-title>. <source>Neural Plast</source>. (<year>2016</year>) <volume>2016</volume>:<fpage>9674790</fpage>. <pub-id pub-id-type="doi">10.1155/2016/9674790</pub-id><pub-id pub-id-type="pmid">27830094</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarso</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Faria</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Leigh</surname><given-names>R</given-names></name><name><surname>Sebastian</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Distinct mechanisms and timing of language recovery after stroke</article-title>. <source>Cogn Neuropsychol</source>. (<year>2013</year>) <volume>30</volume>:<fpage>454</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1080/02643294.2013.875467</pub-id><pub-id pub-id-type="pmid">24472056</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lidzba</surname><given-names>K</given-names></name><name><surname>Staudt</surname><given-names>M</given-names></name><name><surname>Zieske</surname><given-names>F</given-names></name><name><surname>Schwilling</surname><given-names>E</given-names></name><name><surname>Ackermann</surname><given-names>H</given-names></name></person-group>. <article-title>Prestroke/poststroke fMRI in aphasia: perilesional hemodynamic activation and language recovery</article-title>. <source>Neurology.</source> (<year>2012</year>) <volume>78</volume>:<fpage>289</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e318243679a</pub-id><pub-id pub-id-type="pmid">22238411</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldassarre</surname><given-names>A</given-names></name><name><surname>Ramsey</surname><given-names>LE</given-names></name><name><surname>Siegel</surname><given-names>JS</given-names></name><name><surname>Shulman</surname><given-names>GL</given-names></name><name><surname>Corbetta</surname><given-names>M</given-names></name></person-group>. <article-title>Brain connectivity and neurological disorders after stroke</article-title>. <source>Curr Opin Neurol</source>. (<year>2016</year>) <volume>29</volume>:<fpage>706</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000396</pub-id><pub-id pub-id-type="pmid">27749394</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sexton</surname><given-names>EA-O</given-names></name><name><surname>McLoughlin</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>DJ</given-names></name><name><surname>Merriman</surname><given-names>NA</given-names></name><name><surname>Donnelly</surname><given-names>N</given-names></name><name><surname>Rohde</surname><given-names>DA-O</given-names></name><etal/></person-group>. <article-title>Systematic review and meta-analysis of the prevalence of cognitive impairment no dementia in the first year post-stroke</article-title>. <source>Eur Stroke J.</source> (<year>2019</year>) <volume>4</volume>:<fpage>160</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1177/2396987318825484</pub-id><pub-id pub-id-type="pmid">31259264</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>JH</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>JT</given-names></name></person-group>. <article-title>Post-stroke cognitive impairment: epidemiology, mechanisms and management</article-title>. <source>Ann Transl Med</source>. (<year>2014</year>) <volume>2</volume>:<fpage>80</fpage>. <pub-id pub-id-type="doi">10.3978/j.issn.2305-5839.2014.08.05</pub-id><pub-id pub-id-type="pmid">25333055</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melkas</surname><given-names>S</given-names></name><name><surname>Jokinen</surname><given-names>H</given-names></name><name><surname>Hietanen</surname><given-names>M</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name></person-group>. <article-title>Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatment</article-title>. <source>Degener Neurol Neuromuscul Dis.</source> (<year>2014</year>) <volume>4</volume>:<fpage>21</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.2147/DNND.S37353</pub-id><pub-id pub-id-type="pmid">32669898</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>C</given-names></name><name><surname>Rowan</surname><given-names>E</given-names></name><name><surname>Stephens</surname><given-names>S</given-names></name><name><surname>Kalaria</surname><given-names>R</given-names></name><name><surname>Kenny</surname><given-names>RA</given-names></name></person-group>. <article-title>Prospective follow-up study between 3 and 15 months after stroke: improvements and decline in cognitive function among dementia-free stroke survivors &gt;75 years of age</article-title>. <source>Stroke</source>. (<year>2003</year>) <volume>34</volume>:<fpage>2440</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.0000089923.29724.CE</pub-id><pub-id pub-id-type="pmid">14512580</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liman</surname><given-names>TG</given-names></name><name><surname>Heuschmann</surname><given-names>PU</given-names></name><name><surname>Endres</surname><given-names>M</given-names></name><name><surname>Flöel</surname><given-names>A</given-names></name><name><surname>Schwab</surname><given-names>S</given-names></name><name><surname>Kolominsky-Rabas</surname><given-names>PL</given-names></name></person-group>. <article-title>Changes in cognitive function over 3 years after first-ever stroke and predictors of cognitive impairment and long-term cognitive stability: the Erlangen Stroke Project</article-title>. <source>Dement Geriatr Cogn Disord.</source> (<year>2011</year>) <volume>31</volume>:<fpage>291</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1159/000327358</pub-id><pub-id pub-id-type="pmid">21502760</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desmond</surname><given-names>DW</given-names></name><name><surname>Moroney</surname><given-names>JT</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Stern</surname><given-names>Y</given-names></name></person-group>. <article-title>Recovery of cognitive function after stroke</article-title>. <source>Stroke.</source> (<year>1996</year>) <volume>27</volume>:<fpage>1798</fpage>–<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1161/01.STR.27.10.1798</pub-id><pub-id pub-id-type="pmid">8841333</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obaid</surname><given-names>M</given-names></name><name><surname>Flach</surname><given-names>C</given-names></name><name><surname>Marshall</surname><given-names>I</given-names></name><name><surname>C</surname><given-names>DAW</given-names></name><name><surname>Douiri</surname><given-names>A</given-names></name></person-group>. <article-title>Long-term outcomes in stroke patients with cognitive impairment: a population-based study</article-title>. <source>Geriatrics</source>. 5:32. (<year>2020</year>). <pub-id pub-id-type="doi">10.3390/geriatrics5020032</pub-id><pub-id pub-id-type="pmid">32443398</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casolla</surname><given-names>B</given-names></name><name><surname>Caparros</surname><given-names>F</given-names></name><name><surname>Cordonnier</surname><given-names>C</given-names></name><name><surname>Bombois</surname><given-names>S</given-names></name><name><surname>Hénon</surname><given-names>H</given-names></name><name><surname>Bordet</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Biological and imaging predictors of cognitive impairment after stroke: a systematic review</article-title>. <source>J Neurol</source>. (<year>2019</year>) <volume>266</volume>:<fpage>2593</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-018-9089-z</pub-id><pub-id pub-id-type="pmid">30350168</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edlow</surname><given-names>BL</given-names></name><name><surname>Claassen</surname><given-names>J</given-names></name><name><surname>Schiff</surname><given-names>ND</given-names></name><name><surname>Greer</surname><given-names>DM</given-names></name></person-group>. <article-title>Recovery from disorders of consciousness: mechanisms, prognosis and emerging therapies</article-title>. <source>Nat Rev Neurol.</source> (<year>2021</year>) <volume>17</volume>:<fpage>135</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-020-00428-x</pub-id><pub-id pub-id-type="pmid">33318675</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>S</given-names></name><name><surname>de Pasquale</surname><given-names>F</given-names></name><name><surname>Vuillaume</surname><given-names>C</given-names></name><name><surname>Riu</surname><given-names>B</given-names></name><name><surname>Loubinoux</surname><given-names>I</given-names></name><name><surname>Geeraerts</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Disruption of posteromedial large-scale neural communication predicts recovery from coma</article-title>. <source>Neurology</source>. (<year>2015</year>) <volume>85</volume>:<fpage>2036</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000002196</pub-id><pub-id pub-id-type="pmid">26561296</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soch</surname><given-names>J</given-names></name><name><surname>Richter</surname><given-names>A</given-names></name><name><surname>Schütze</surname><given-names>H</given-names></name><name><surname>Kizilirmak</surname><given-names>JM</given-names></name><name><surname>Assmann</surname><given-names>A</given-names></name><name><surname>Behnisch</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>A comprehensive score reflecting memory-related fMRI activations and deactivations as potential biomarker for neurocognitive aging</article-title>. <source>Hum Brain Mapp.</source> (<year>2021</year>) <volume>42</volume>:<fpage>4478</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.25559</pub-id><pub-id pub-id-type="pmid">34132437</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhalla</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Rudd</surname><given-names>A</given-names></name><name><surname>Wolfe</surname><given-names>CD</given-names></name></person-group>. <article-title>Differences in outcome and predictors between ischemic and intracerebral hemorrhage: the South London Stroke Register</article-title>. <source>Stroke.</source> (<year>2013</year>) <volume>44</volume>:<fpage>2174</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.113.001263</pub-id><pub-id pub-id-type="pmid">23813988</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>JW</given-names></name><name><surname>Heeley</surname><given-names>EL</given-names></name><name><surname>Wang</surname><given-names>JG</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>LK</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Comparison of recovery patterns and prognostic indicators for ischemic and hemorrhagic stroke in China: the ChinaQUEST (QUality Evaluation of Stroke Care and Treatment) Registry study</article-title>. <source>Stroke</source>. (<year>2010</year>) <volume>41</volume>:<fpage>1877</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.110.586909</pub-id><pub-id pub-id-type="pmid">20651267</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>AG</given-names></name><name><surname>Ay</surname><given-names>H</given-names></name></person-group>. <article-title>Transient ischemic attack: definition, diagnosis, risk stratification</article-title>. <source>Neuroimaging Clin N Am.</source> (<year>2011</year>) <volume>21</volume>:<fpage>303</fpage>. <pub-id pub-id-type="doi">10.1016/j.nic.2011.01.013</pub-id><pub-id pub-id-type="pmid">21640301</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname><given-names>AL</given-names></name><name><surname>Silvestrini</surname><given-names>M</given-names></name><name><surname>Topakian</surname><given-names>R</given-names></name><name><surname>Golledge</surname><given-names>J</given-names></name><name><surname>Brunser</surname><given-names>AM</given-names></name><name><surname>de Borst</surname><given-names>GJ</given-names></name><etal/></person-group>. <article-title>Optimizing the definitions of stroke, transient ischemic attack, and infarction for research and application in clinical practice</article-title>. <source>Front Neurol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>537</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00537</pub-id><pub-id pub-id-type="pmid">29104559</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>RF</given-names></name><name><surname>Hillis</surname><given-names>AE</given-names></name></person-group>. <article-title>Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke</article-title>. <source>Lancet Neurol</source>. (<year>2010</year>) <volume>9</volume>:<fpage>895</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(10)70164-2</pub-id><pub-id pub-id-type="pmid">20723846</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Combination of serum neurofilament light chain levels and MRI markers to predict cognitive function in ischemic stroke</article-title>. <source>Neurorehabil Neural Repair.</source> (<year>2021</year>) <volume>35</volume>:<fpage>247</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1177/1545968321989354</pub-id><pub-id pub-id-type="pmid">33522401</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagnier</surname><given-names>S</given-names></name><name><surname>Catheline</surname><given-names>G</given-names></name><name><surname>Munsch</surname><given-names>F</given-names></name><name><surname>Bigourdan</surname><given-names>A</given-names></name><name><surname>Poli</surname><given-names>M</given-names></name><name><surname>Debruxelles</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Severity of small vessel disease biomarkers reduces the magnitude of cognitive recovery after ischemic stroke</article-title>. <source>Cerebrovasc Dis</source>. (<year>2021</year>) <volume>50</volume>:<fpage>456</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1159/000513916</pub-id><pub-id pub-id-type="pmid">33827075</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagnier</surname><given-names>S</given-names></name><name><surname>Okubo</surname><given-names>G</given-names></name><name><surname>Catheline</surname><given-names>G</given-names></name><name><surname>Munsch</surname><given-names>F</given-names></name><name><surname>Bigourdan</surname><given-names>A</given-names></name><name><surname>Debruxelles</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Chronic cortical cerebral microinfarcts slow down cognitive recovery after acute ischemic stroke</article-title>. <source>Stroke.</source> (<year>2019</year>) <volume>50</volume>:<fpage>1430</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.024672</pub-id><pub-id pub-id-type="pmid">31084336</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicentini</surname><given-names>JE</given-names></name><name><surname>Weiler</surname><given-names>M</given-names></name><name><surname>Casseb</surname><given-names>RF</given-names></name><name><surname>Almeida</surname><given-names>SR</given-names></name><name><surname>Valler</surname><given-names>L</given-names></name><name><surname>de Campos</surname><given-names>BM</given-names></name><etal/></person-group>. <article-title>Subacute functional connectivity correlates with cognitive recovery six months after stroke</article-title>. <source>Neuroimage Clin.</source> (<year>2021</year>) <volume>29</volume>:<fpage>102538</fpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2020.102538</pub-id><pub-id pub-id-type="pmid">33385880</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fruhwirth</surname><given-names>V</given-names></name><name><surname>Enzinger</surname><given-names>C</given-names></name><name><surname>Fandler-Höfler</surname><given-names>S</given-names></name><name><surname>Kneihsl</surname><given-names>M</given-names></name><name><surname>Eppinger</surname><given-names>S</given-names></name><name><surname>Ropele</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Baseline white matter hyperintensities affect the course of cognitive function after small vessel disease-related stroke: a prospective observational study</article-title>. <source>Eur J Neurol</source>. (<year>2021</year>) <volume>28</volume>:<fpage>401</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1111/ene.14593</pub-id><pub-id pub-id-type="pmid">33065757</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>AC</given-names></name><name><surname>Gronewold</surname><given-names>J</given-names></name><name><surname>Todica</surname><given-names>O</given-names></name><name><surname>Moenninghoff</surname><given-names>C</given-names></name><name><surname>Doeppner</surname><given-names>TR</given-names></name><name><surname>de Haan</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Evolution of neuropsychological deficits in first-ever isolated ischemic thalamic stroke and their association with stroke topography: a case-control study</article-title>. <source>Stroke.</source> (<year>2022</year>) <volume>53</volume>:<fpage>1904</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.121.037750</pub-id><pub-id pub-id-type="pmid">35259928</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagnier</surname><given-names>S</given-names></name><name><surname>Catheline</surname><given-names>G</given-names></name><name><surname>Dilharreguy</surname><given-names>B</given-names></name><name><surname>Munsch</surname><given-names>F</given-names></name><name><surname>Bigourdan</surname><given-names>A</given-names></name><name><surname>Poli</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Admission brain cortical volume: an independent determinant of poststroke cognitive vulnerability</article-title>. <source>Stroke.</source> (<year>2017</year>) <volume>48</volume>:<fpage>2113</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.117.017646</pub-id><pub-id pub-id-type="pmid">28626050</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>PS</given-names></name><name><surname>Lee</surname><given-names>KP</given-names></name><name><surname>Lin</surname><given-names>PY</given-names></name><name><surname>Su</surname><given-names>HC</given-names></name><name><surname>Yu</surname><given-names>RL</given-names></name><name><surname>Tsai</surname><given-names>KJ</given-names></name><etal/></person-group>. <article-title>Factors associated with cognitive outcomes after first-ever ischemic stroke: the impact of small vessel disease burden and neurodegeneration</article-title>. <source>J Alzheimers Dis</source>. (<year>2021</year>) <volume>83</volume>:<fpage>569</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-210587</pub-id><pub-id pub-id-type="pmid">34334409</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turunen</surname><given-names>KE</given-names></name><name><surname>Kauranen</surname><given-names>TV</given-names></name><name><surname>Laari</surname><given-names>SP</given-names></name><name><surname>Mustanoja</surname><given-names>SM</given-names></name><name><surname>Tatlisumak</surname><given-names>T</given-names></name><name><surname>Poutiainen</surname><given-names>ET</given-names></name></person-group>. <article-title>Cognitive deficits after subcortical infarction are comparable with deficits after cortical infarction</article-title>. <source>Eur J Neurol</source>. (<year>2013</year>) <volume>20</volume>:<fpage>286</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2012.03844.x</pub-id><pub-id pub-id-type="pmid">22934686</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Infarct location and cognitive change in patients after acute ischemic stroke: the ICONS study</article-title>. <source>J Neurol Sci.</source> (<year>2022</year>) <volume>438</volume>:<fpage>120276</fpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2022.120276</pub-id><pub-id pub-id-type="pmid">35617844</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aben</surname><given-names>HP</given-names></name><name><surname>Biessels</surname><given-names>GJ</given-names></name><name><surname>Weaver</surname><given-names>NA</given-names></name><name><surname>Spikman</surname><given-names>JM</given-names></name><name><surname>Visser-Meily</surname><given-names>JMA</given-names></name><name><surname>de Kort</surname><given-names>PLM</given-names></name><etal/></person-group>. <article-title>Extent to which network hubs are affected by ischemic stroke predicts cognitive recovery</article-title>. <source>Stroke.</source> (<year>2019</year>) <volume>50</volume>:<fpage>2768</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.119.025637</pub-id><pub-id pub-id-type="pmid">31743084</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aben</surname><given-names>HP</given-names></name><name><surname>De Munter</surname><given-names>L</given-names></name><name><surname>Reijmer</surname><given-names>YD</given-names></name><name><surname>Spikman</surname><given-names>JM</given-names></name><name><surname>Visser-Meily</surname><given-names>JMA</given-names></name><name><surname>Biessels</surname><given-names>GJ</given-names></name><etal/></person-group>. <article-title>Prediction of cognitive recovery after stroke: the value of diffusion-weighted imaging-based measures of brain connectivity</article-title>. <source>Stroke.</source> (<year>2021</year>) <volume>52</volume>:<fpage>1983</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.032033</pub-id><pub-id pub-id-type="pmid">33966494</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuceyeski</surname><given-names>A</given-names></name><name><surname>Navi</surname><given-names>BB</given-names></name><name><surname>Kamel</surname><given-names>H</given-names></name><name><surname>Raj</surname><given-names>A</given-names></name><name><surname>Relkin</surname><given-names>N</given-names></name><name><surname>Toglia</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Structural connectome disruption at baseline predicts 6-months post-stroke outcome</article-title>. <source>Hum Brain Mapp</source>. (<year>2016</year>) <volume>37</volume>:<fpage>2587</fpage>–<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.23198</pub-id><pub-id pub-id-type="pmid">27016287</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tong</surname><given-names>E</given-names></name><name><surname>Williams</surname><given-names>LM</given-names></name><name><surname>Zaharchuk</surname><given-names>G</given-names></name><name><surname>Zeineh</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Resting-state functional MRI: everything that nonexperts have always wanted to know</article-title>. <source>AJNR Am J Neuroradiol</source>. (<year>2018</year>) <volume>39</volume>:<fpage>1390</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A5527</pub-id><pub-id pub-id-type="pmid">29348136</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>L</given-names></name><name><surname>Liang</surname><given-names>P</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name></person-group>. <article-title>Disrupted brain connectivity networks in acute ischemic stroke patients</article-title>. <source>Brain Imaging Behav.</source> (<year>2017</year>) <volume>11</volume>:<fpage>444</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/s11682-016-9525-6</pub-id><pub-id pub-id-type="pmid">26883758</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>JS</given-names></name><name><surname>Ramsey</surname><given-names>LE</given-names></name><name><surname>Snyder</surname><given-names>AZ</given-names></name><name><surname>Metcalf</surname><given-names>NV</given-names></name><name><surname>Chacko</surname><given-names>RV</given-names></name><name><surname>Weinberger</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Disruptions of network connectivity predict impairment in multiple behavioral domains after stroke</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2016</year>) <volume>113</volume>:<fpage>E4367</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1521083113</pub-id><pub-id pub-id-type="pmid">27402738</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Decreased functional connectivity of homotopic brain regions in chronic stroke patients: a resting state fMRI study</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0152875</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0152875</pub-id><pub-id pub-id-type="pmid">27074031</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohenfeld</surname><given-names>C</given-names></name><name><surname>Werner</surname><given-names>CJ</given-names></name><name><surname>Reetz</surname><given-names>K</given-names></name></person-group>. <article-title>Resting-state connectivity in neurodegenerative disorders: is there potential for an imaging biomarker?</article-title>
<source>Neuroimage Clin.</source> (<year>2018</year>) <volume>18</volume>:<fpage>849</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.nicl.2018.03.013</pub-id><pub-id pub-id-type="pmid">29876270</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>E</given-names></name><name><surname>Altendorff</surname><given-names>S</given-names></name><name><surname>Healy</surname><given-names>C</given-names></name><name><surname>Werring</surname><given-names>DJ</given-names></name><name><surname>Cipolotti</surname><given-names>L</given-names></name></person-group>. <article-title>The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation</article-title>. <source>J Neurol Sci.</source> (<year>2017</year>) <volume>373</volume>:<fpage>100</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2016.12.028</pub-id><pub-id pub-id-type="pmid">28131163</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perna</surname><given-names>R</given-names></name><name><surname>Temple</surname><given-names>J</given-names></name></person-group>. <article-title>Rehabilitation outcomes: ischemic versus hemorrhagic strokes</article-title>. <source>Behav Neurol.</source> (<year>2015</year>) <volume>2015</volume>:<fpage>891651</fpage>. <pub-id pub-id-type="doi">10.1155/2015/891651</pub-id><pub-id pub-id-type="pmid">26246694</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reitz</surname><given-names>C</given-names></name><name><surname>Bos</surname><given-names>MJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Koudstaal</surname><given-names>PJ</given-names></name><name><surname>Breteler</surname><given-names>MMB</given-names></name></person-group>. <article-title>Prestroke cognitive performance, incident stroke, and risk of dementia</article-title>. <source>Stroke.</source> (<year>2008</year>) <volume>39</volume>:<fpage>36</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.490334</pub-id><pub-id pub-id-type="pmid">18006863</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kandiah</surname><given-names>N</given-names></name><name><surname>Chander</surname><given-names>RJ</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Poh</surname><given-names>YY</given-names></name><name><surname>Cheong</surname><given-names>CY</given-names></name><etal/></person-group>. <article-title>Cognitive impairment after mild stroke: development and validation of the SIGNAL2 risk score</article-title>. <source>J Alzheimers Dis.</source> (<year>2016</year>) <volume>49</volume>:<fpage>1169</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-150736</pub-id><pub-id pub-id-type="pmid">26599056</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chander</surname><given-names>RJ</given-names></name><name><surname>Lam</surname><given-names>BYK</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Ng</surname><given-names>AYT</given-names></name><name><surname>Wong</surname><given-names>APL</given-names></name><name><surname>Mok</surname><given-names>VCT</given-names></name><etal/></person-group>. <article-title>Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke</article-title>. <source>Sci Rep</source>. (<year>2017</year>) <volume>7</volume>:<fpage>12441</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-12755-z</pub-id><pub-id pub-id-type="pmid">28963553</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
